• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

避孕咨询和心血管疾病女性避孕措施的采用:系统评价和荟萃分析。

Contraceptive counselling and uptake of contraception among women with cardiovascular diseases: a systematic review and meta-analysis.

机构信息

Deakin Rural Health, School of Medicine, Deakin University, Warrnambool, Australia.

Geohealth Laboratory, Dasman Diabetes Institute, 15462, Kuwait City, Kuwait.

出版信息

Clin Res Cardiol. 2024 Aug;113(8):1151-1170. doi: 10.1007/s00392-024-02472-9. Epub 2024 Jul 10.

DOI:10.1007/s00392-024-02472-9
PMID:38985159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11269356/
Abstract

To address the lack of clarity regarding contraceptive counselling and uptake of contraception among women with cardiovascular disease (CVD), this study aimed to conduct a systematic review and meta-analysis on contraceptive counselling and the subsequent uptake of contraception among women with CVD. A search across six databases identified 1228 articles, with 11 studies (2580 participants) included. The pooled prevalence of contraceptive counselling was 63%, varying from 36 to 94% in individual studies. Inconsistent delivery and documentation of counselling were noted, along with a lack of knowledge about pregnancy complications and misconceptions regarding CVD severity. For contraceptive uptake (n = 5), the pooled prevalence was 64% (95% confidence interval, 45 to 82%). Women with CVD were also found to use less effective methods as well as methods not recommended for their condition (e.g., combined hormonal methods among participants with absolute or relative contraindications). Improving contraceptive counselling and choices for women with CVD can not only enhance knowledge and decision-making for women with CVD in line with their reproductive goals and preferences but reduce high-risk unintended pregnancies and adverse pregnancy outcomes.

摘要

为了解决心血管疾病 (CVD) 女性在避孕咨询和避孕措施使用方面的不明确问题,本研究旨在对 CVD 女性的避孕咨询及其后续避孕措施使用情况进行系统评价和荟萃分析。通过对六个数据库进行搜索,共确定了 1228 篇文章,其中包括 11 项研究(2580 名参与者)。避孕咨询的总体流行率为 63%,在个别研究中从 36%到 94%不等。研究中注意到咨询的提供和记录不一致,并且对妊娠并发症的认识不足,对 CVD 严重程度存在误解。对于避孕措施的使用(n=5),总体流行率为 64%(95%置信区间,45%至 82%)。还发现 CVD 女性使用的方法效果较差,且不适合其病情(例如,有绝对或相对禁忌症的参与者中使用复方激素方法)。改善 CVD 女性的避孕咨询和选择不仅可以增强符合 CVD 女性生殖目标和偏好的知识和决策能力,还可以减少高风险的非意愿妊娠和不良妊娠结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/3f9371d8466f/392_2024_2472_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/38adffdf7c30/392_2024_2472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/aa08fb1e95bb/392_2024_2472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/d7456d1fc9ea/392_2024_2472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/b975bca771de/392_2024_2472_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/2ba590794cef/392_2024_2472_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/5b8ff6c587f8/392_2024_2472_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/3f9371d8466f/392_2024_2472_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/38adffdf7c30/392_2024_2472_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/aa08fb1e95bb/392_2024_2472_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/d7456d1fc9ea/392_2024_2472_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/b975bca771de/392_2024_2472_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/2ba590794cef/392_2024_2472_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/5b8ff6c587f8/392_2024_2472_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e487/11269356/3f9371d8466f/392_2024_2472_Fig7_HTML.jpg

相似文献

1
Contraceptive counselling and uptake of contraception among women with cardiovascular diseases: a systematic review and meta-analysis.避孕咨询和心血管疾病女性避孕措施的采用:系统评价和荟萃分析。
Clin Res Cardiol. 2024 Aug;113(8):1151-1170. doi: 10.1007/s00392-024-02472-9. Epub 2024 Jul 10.
2
Behavioral interventions for improving contraceptive use among women living with HIV.改善感染艾滋病毒妇女避孕措施使用情况的行为干预措施。
Cochrane Database Syst Rev. 2013 Jan 31(1):CD010243. doi: 10.1002/14651858.CD010243.pub2.
3
Behavioral interventions for improving contraceptive use among women living with HIV.改善感染艾滋病毒女性避孕措施使用情况的行为干预措施。
Cochrane Database Syst Rev. 2016 Aug 9;2016(8):CD010243. doi: 10.1002/14651858.CD010243.pub3.
4
Brief educational strategies for improving contraception use in young people.提高年轻人避孕措施使用率的简短教育策略。
Cochrane Database Syst Rev. 2016 Mar 30;3(3):CD012025. doi: 10.1002/14651858.CD012025.pub2.
5
Inequality in modern contraceptive use and unmet need for contraception among women of reproductive age in Zambia. A trend and decomposition analysis 2007-2018.赞比亚育龄妇女现代避孕方法使用情况及未满足的避孕需求的不平等。2007 - 2018年趋势与分解分析
Reprod Health. 2024 Dec 9;21(1):181. doi: 10.1186/s12978-024-01909-8.
6
Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.已知患有血脂异常的女性使用复方激素避孕药:对关键安全性结局的系统评价
Contraception. 2016 Sep;94(3):280-7. doi: 10.1016/j.contraception.2015.08.002. Epub 2015 Aug 10.
7
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
8
Postpartum intrauterine contraceptive device use and its associated factors in Ethiopia: systematic review and meta-analysis.埃塞俄比亚产后宫内节育器使用及其相关因素:系统评价和荟萃分析。
Reprod Health. 2021 Nov 13;18(1):225. doi: 10.1186/s12978-021-01273-x.
9
Hormonal contraceptives for contraception in overweight or obese women.超重或肥胖女性避孕用激素避孕药
Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4.
10
Chatbots That Deliver Contraceptive Support: Systematic Review.提供避孕支持的聊天机器人:系统评价。
J Med Internet Res. 2024 Feb 27;26:e46758. doi: 10.2196/46758.

引用本文的文献

1
Rheumatic Heart Disease and Contraception Use in Ethiopia: A Cross-Sectional Study.埃塞俄比亚的风湿性心脏病与避孕措施使用情况:一项横断面研究
Cureus. 2025 Jul 22;17(7):e88541. doi: 10.7759/cureus.88541. eCollection 2025 Jul.
2
Comment on "Contraception Use in Adolescents and Young Adults with Congenital Heart Disease".关于《先天性心脏病青少年和青年的避孕措施使用情况》的评论
Pediatr Cardiol. 2025 Mar 21. doi: 10.1007/s00246-025-03838-0.

本文引用的文献

1
Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis.避孕措施的使用和避孕咨询干预对有生育能力的癌症女性:系统评价和荟萃分析。
BMC Med. 2022 Dec 17;20(1):489. doi: 10.1186/s12916-022-02690-w.
2
Contraception in Women With Cardiovascular Disease.心血管疾病女性的避孕
JAMA. 2022 Aug 9;328(6):577-578. doi: 10.1001/jama.2022.11541.
3
Unmet need for contraception and associated factors among women with cardiovascular disease having follow-up at Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia: a cross-sectional study.
埃塞俄比亚亚的斯亚贝巴圣保罗医院千禧医学院随访的心血管疾病女性中未满足的避孕需求及相关因素:一项横断面研究
Contracept Reprod Med. 2022 May 11;7(1):6. doi: 10.1186/s40834-022-00173-0.
4
Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study.澳大利亚患有慢性病的年轻女性避孕方式的使用模式:一项前瞻性队列研究的结果。
Reprod Health. 2022 May 7;19(1):111. doi: 10.1186/s12978-022-01413-x.
5
Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women.女性心血管疾病的妊娠和生殖风险因素。
Circ Res. 2022 Feb 18;130(4):652-672. doi: 10.1161/CIRCRESAHA.121.319895. Epub 2022 Feb 17.
6
Adolescents With Congenital Heart Disease: What Do They Know About Reproductive Health and Risks?先天性心脏病青少年:他们对生殖健康和风险了解多少?
J Cardiovasc Nurs. 2022;37(6):E172-E180. doi: 10.1097/JCN.0000000000000838. Epub 2021 Jul 6.
7
Pre-conceptual counselling in cardiology patients: still work to do and still missed opportunities. A comparison between 2015 and 2019 in women with cardiac disease attending combined obstetric cardiology clinics. Should the European Guidelines change anything?先证期咨询在心血管病患者中:仍有工作要做,仍有错失的机会。比较 2015 年和 2019 年在联合妇产科心脏病诊所就诊的心脏病女性患者。欧洲指南应该改变什么吗?
Cardiol Young. 2022 Jan;32(1):64-70. doi: 10.1017/S1047951121001530. Epub 2021 May 25.
8
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.柳叶刀妇女与心血管疾病委员会:到 2030 年降低全球负担。
Lancet. 2021 Jun 19;397(10292):2385-2438. doi: 10.1016/S0140-6736(21)00684-X. Epub 2021 May 16.
9
Contraception and Reproductive Planning for Women With Cardiovascular Disease: JACC Focus Seminar 5/5.患有心血管疾病女性的避孕与生殖计划:JACC 焦点研讨会 5/5。
J Am Coll Cardiol. 2021 Apr 13;77(14):1823-1834. doi: 10.1016/j.jacc.2021.02.025.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.